You are here: Home » News-CM » Companies » Results
Business Standard

Jagsonpal Pharmaceuticals standalone net profit rises 31.03% in the December 2019 quarter

Capital Market 

Sales rise 0.29% to Rs 42.01 crore

Net profit of Jagsonpal Pharmaceuticals rose 31.03% to Rs 2.28 crore in the quarter ended December 2019 as against Rs 1.74 crore during the previous quarter ended December 2018. Sales rose 0.29% to Rs 42.01 crore in the quarter ended December 2019 as against Rs 41.89 crore during the previous quarter ended December 2018. ParticularsQuarter EndedDec. 2019Dec. 2018% Var.Sales42.0141.89 0 OPM %6.095.23 -PBDT3.112.37 31 PBT2.852.14 33 NP2.281.74 31

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Fri, February 14 2020. 12:49 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU